13D/13G Filings - Aztiq Pharma Partners S.a r.l.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-07-03
5:31 pm
Unchanged
2024-07-01 13D Alvotech
ALVO
Aztiq Pharma Partners S.a r.l. 101,147,803
33.500%
0
(Unchanged)
Filing
History
2022-07-18
4:03 pm
Purchase
2022-07-12 13D Alvotech
ALVO
Aztiq Pharma Partners S.a r.l. 101,147,803
40.680%
2,500,000increase
(+2.53%)
Filing
History
2022-07-01
6:19 pm
Purchase
2022-06-15 13D Alvotech
ALVO
Aztiq Pharma Partners S.a r.l. 98,647,803
40.490%
98,647,803increase
(New Position)
Filing
History